Elizabeth A. Connolly
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Elizabeth A. Connolly has a total of 186 co-authors. Here are the top co-authors by number of shared publications:
- Adel T. Aref
ProCan, Children’s Medical Research Institute, Faculty of Medicine and Health, The University of Sydney, Westmead, Australia
19 shared publications - Adnan Nagrial
The University of Sydney, Sydney, Australia
19 shared publications - Adriana Aguilar-Mahecha
McGill University 1 Lady Davis Institute Montreal, Canada
19 shared publications - Alexander Swarbrick
Cancer Ecosystems Program, Garvan Institute of Medical Research, Darlinghurst, Australia
19 shared publications - Anna DeFazio
The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, Australia
19 shared publications - Anthony J. Gill
Sydney Medical School, University of Sydney, Sydney
19 shared publications
Latest Publications
- Open Access
- 4 September 2025
- Published by American Association for Cancer Research (AACR)
Table S4 from Federated Deep Learning Enables Cancer Subtyping by Proteomics
Per class AUROC using ProCan Compendium and external datasets
- 4 September 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S4 from Federated Deep Learning Enables Cancer Subtyping by Proteomics
Per class AUROC using ProCan Compendium and external datasets
- Open Access
- 4 September 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 7 from Federated Deep Learning Enables Cancer Subtyping by Proteomics
ProCanFDL with external datasets
- 4 September 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 7 from Federated Deep Learning Enables Cancer Subtyping by Proteomics
ProCanFDL with external datasets
- Open Access
- 4 September 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 5 from Federated Deep Learning Enables Cancer Subtyping by Proteomics
Sample sizes of Sites 1-4 across ten experiments
- 4 September 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 5 from Federated Deep Learning Enables Cancer Subtyping by Proteomics
Sample sizes of Sites 1-4 across ten experiments
- Open Access
- 4 September 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 1 from Federated Deep Learning Enables Cancer Subtyping by Proteomics
- 4 September 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 1 from Federated Deep Learning Enables Cancer Subtyping by Proteomics
- Open Access
- 4 September 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 12 from Federated Deep Learning Enables Cancer Subtyping by Proteomics
Protein overlap between global and local models based on SHAP rankings
- 4 September 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 12 from Federated Deep Learning Enables Cancer Subtyping by Proteomics
Protein overlap between global and local models based on SHAP rankings
- Open Access
- 4 September 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 8 from Federated Deep Learning Enables Cancer Subtyping by Proteomics
Effects of adding external datasets
- 4 September 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 8 from Federated Deep Learning Enables Cancer Subtyping by Proteomics
Effects of adding external datasets
- Open Access
- 4 September 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 2 from Federated Deep Learning Enables Cancer Subtyping by Proteomics
- 4 September 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 2 from Federated Deep Learning Enables Cancer Subtyping by Proteomics
- Open Access
- 4 September 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 11 from Federated Deep Learning Enables Cancer Subtyping by Proteomics
Pathway analysis of top SHAP-ranked proteins across cancer subtypes
- 4 September 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 11 from Federated Deep Learning Enables Cancer Subtyping by Proteomics
Pathway analysis of top SHAP-ranked proteins across cancer subtypes
- Open Access
- 4 September 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 13 from Federated Deep Learning Enables Cancer Subtyping by Proteomics
SHAP values of antibody drug conjugate targets across cancer subtypes
- 4 September 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 13 from Federated Deep Learning Enables Cancer Subtyping by Proteomics
SHAP values of antibody drug conjugate targets across cancer subtypes
- Open Access
- 4 September 2025
- Published by American Association for Cancer Research (AACR)
Table S5 from Federated Deep Learning Enables Cancer Subtyping by Proteomics
Feature importance for cancer subtype prediction using SHAP.
- 4 September 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S5 from Federated Deep Learning Enables Cancer Subtyping by Proteomics
Feature importance for cancer subtype prediction using SHAP.